Stefan Mark Nidorf

8PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersToxicology (incl. clinical toxicology)Epidemiological modellingMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 15, 2025
Cardiovascular Benefit of Colchicine in Relation to Baseline Risk: A Secondary Analysis of the LoDoCo2 Trial.

Niekbachsh Mohammadnia, Britta E Wesselink, Willem A Bax

|Apr 10, 2024
Low-dose colchicine for atherosclerosis: long-term safety.

Stefan Mark Nidorf, Eldad Ben-Chetrit, Paul M Ridker

|Jul 06, 2023
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease.

Pascal M Burger, Jannick A N Dorresteijn, Aernoud T L Fiolet

|May 07, 2021
Colchicine and the heart.

Massimo Imazio, Mark Nidorf

Pageof 2